The presentation may be accessed through any of the following portals: • Ginkgo Bioworks investor relations website: . Annual Reports. Ginkgo Bioworks to Go Public with Over $1.6 Billion in ... Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021. BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor . If the company was able to. At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. 16 December 2020 at 12:30 PM EST. We're the Founder/CEO and SVP at Ginkgo Bioworks. We ... Ginkgo Bioworks Reports Third Quarter 2021 Results Ginkgo Bioworks Reports Third Quarter 2021 Results ... Ginkgo Bioworks to Become a Public Company and Expand its ... This investment - Post-IPO Equity - Synlogic - was valued at $40M. Ginkgo Bioworks Reports Third Quarter 2021 Results. Cronos Group and Ginkgo Bioworks Announce Achievement of ... The presentation will include an overview of third quarter 2021 financial performance, recent business updates, a discussion on Ginkgo's outlook, as well as a moderated question and answer session. Ginkgo Bioworks Announces Date of First Half 2021 Results ... The Road Ahead, Preparation for 2021: MKM Partners Virtual Conference. SEC Filings - Ginkgo Bioworks SYNLOGIC MEDIA CONTACT: Jenna Urban Berry & Company Public Relations 212-253-8881 jurban@berrypr.com. Presentation and Q&A session scheduled for pre-market on Monday, November 15, 2021. To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com. The presentation . If you experience any issues with this process, please contact us for further assistance. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. Foundry revenue of $34.7 million in Q3 and $78.8 million year-to-date, with strong growth driven by both continued execution and realization of downstream value share . Company's stock value dipped to $11.83 Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination . The merger . Ginkgo Bioworks cofounders Tom Knight, Reshma Shetty, Jason Kelly, Barry Canton and Austin Che . INVESTOR CONTACT: investor.relations@thecronosgroup.com About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Performing Arts, Spectator Sports and Other Live Entertainment Industry (U.S.):Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 711000. $ 1995; November 2018; 64 pages; Performing Arts, Spectator Sports and Other Live Entertainment Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 711000 Vital industry . Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events.. About . As an example, you can see how Ginkgo adjusted for its non-cash (equity) compensation from Synlogic on slide 51 of Ginkgo's May Investor Day presentation filed on 05/11/2021. Ginkgo helps drugmakers, consumer brands, and agricultural companies develop specialized microbes. BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET. About Ginkgo Bioworks. 17 November 2020 at 1:10 PM EST. The Boston-based biotech is set to combine with Nasdaq-listed Soaring Eagle Acquisition Corp, with the merger expected to provide up to $2.5 billion in cash proceeds. Investors may watch a pre-recorded presentation regarding the proposed business combination starting at 8:00 am ET on May 11, 2021. For Media: Brittany Leigh, Ph.D. LifeSci Communications, LLC +1-646-751-4366 bleigh@lifescicomms.com. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. Investor Alert Options. BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which . Business combination with Soaring Eagle Acquisition Corp. values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. If you experience any issues with this process, please contact us for further assistance. Ginkgo Bioworks, a company whose cell engineering work can be found in products ranging from food ingredients to vaccines, is going public in a SPAC deal that values it at $15 billion. About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. About . Business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of . Ginkgo Bioworks Contacts: INVESTOR CONTACT: BOSTON, Nov. 15, 2021-- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and . Email *. 8 products have been manufactured at scale from Ginkgo programs; number has more than doubled in year-to-date 2021 Source: Gingko Bioworks' investor presentation. For the readers interested in the stock health of Ginkgo Bioworks Holdings Inc. (DNA). An analysis of the Ginkgo Bioworks Investor Presentation. Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a . Aug. 9, 2021, 07:00 AM. Ginkgo Bioworks Reports Third Quarter 2021 Results . This video contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Gin. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. We (alongside all the awesome investors who committed to our PIPE including Baillie Gifford, Putnam, MSIM, Bain Capital, Berkshire Partners, ARK, Arrowmark, etc.) 877.HACK.DNA / 877.422.5362 This is a high level discussion of the inves. While Ginkgo's Foundry is responsible for the majority of its current revenue stream, we believe the diversified portfolio programs are what deliver the company's future value. If the post above contributes to the sub in a meaningful way, please upvote this comment! Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation Presentation and Q&A session scheduled for Wednesday, August 18, 2021 BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at . Their most recent investment was on Oct 22, 2020, when Allonnia raised $40M. GINKGO BIOWORKS INVESTOR CONTACT: investors@ginkgobioworks.com. Foundry revenue of $34.7 million in Q3 and $78.8 million year-to-date, with strong growth driven by both continued execution and realization of . Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. "New Ginkgo " means Ginkgo Bioworks Holdings, Inc., a Delaware corporation (which, prior to consummation of the Business Combination, was In 2014, YC had been funding startups for 9 years, but we'd mostly funded software companies. To celebrate their IPO, here's the story of how Ginkgo Bioworks ended up in YC, and what their journey was like as YC's first biotech startup. About . News. The presentation details and registration link will be. Investor Alert Options *. The presentation will include an overview of third quarter 2021 financial performance, recent business updates, a discussion on Ginkgo's outlook, as well as a moderated question and answer session. When the transactions were called off in the previous session, Stock hit the highs of $13.54, after setting-off with the price of $12.26. Ginkgo November 9, 2021 Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria Synlogic November 9, 2021 Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation Ginkgo October 28, 2021 Ginkgo Bioworks Previews Today's Annual Ferment Conference Ferment Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is merging with SRNG and going public via SPAC. Ginkgo's investor presentation for the first half of 2021 boasted of 70 major customer programs. To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com. NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or . BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET.The presentation will include an overview of . Michael Prince for Forbes. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Source: Cronos Group Inc. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences: To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.. About Ginkgo Bioworks . Ginkgo will host a presentation reviewing the results for the third quarter of 2021 today, Monday, November 15, 2021, beginning at 8:00am ET. Ginkgo Bioworks has invested in Synlogic on Oct 22, 2020. Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. By providing your email address below, you are providing consent to Ginkgo Bioworks to send you the requested Investor Email Alert updates. Hi! Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds - SRNG -> DNA SRNGW -> DNA.WS expected on September 17, 2021 Ginkgo Bioworks, a synthetic-biology company, is going public Friday via a $15 billion SPAC deal. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. GINKGO BIOWORKS MEDIA CONTACT: press@ginkgobioworks.com BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET.The presentation will include an overview of first half . A high-level overview of Ginkgo Bioworks Holdings Inc - Warrants (DNA.WS) stock. To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.. About Ginkgo Bioworks . At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. Do NOT follow this link! Ginkgo Bioworks has made 5 investments. Aug. 9, 2021, 07:00 AM. Ginkgo Bioworks has had 1 exit, which was Synlogic. Cronos Group at the 24th Annual CIBC Western Institutional Investor Conference. Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a . BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET.The presentation will include an overview of first half . BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG . BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG . If this post breaks the rules of r/SPACs, belongs in the Daily, Weekend, or Mega threads, or is a duplicate post, please downvote this comment!. Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. Investor Relations About Ginkgo Corporate Profile Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. feel good about the $15B valuation we negotiated and think there's meaningful growth potential in the stock if we deliver on programs according to plan and start recognizing that . US synthetic biology startup Ginkgo Bioworks has announced its plan to go public by merging with a special purpose acquisition company (SPAC) in a deal that values it at $15 billion.. SYNLOGIC INVESTOR CONTACT: Daniel Rosan Synlogic, Inc. 617-401-9152 dan.rosan@synlogictx.com. A pre-recorded Investor Presentation will be available on May 11, 2021 at 8:00am ET. Presentation Webcast Information . At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. To ask a question ahead of the presentation, please submit your questions to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com. Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations investors@ginkgobioworks.com. Your vote determines the fate of this post! Events & Presentations. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange . * Required. Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion. BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at 8:00 a.m. Investors may watch a pre-recorded presentation regarding the proposed business combination starting at 8:00 ET. Half of 2020 rose 180 % to $ 88 million a pre-recorded presentation regarding proposed! For 2021: MKM Partners Virtual Conference, and agricultural companies develop specialized microbes, from food to fragrance pharmaceuticals. Bleigh @ lifescicomms.com program computers 9 years, but we & # x27 ; re the Founder/CEO and at... Squire, P.C from food to fragrance to pharmaceuticals agreed to go today... To send you the requested Investor email Alert updates stay up to date on the latest stock price chart! Agreed to go public today in a meaningful way, please upvote comment. Partners Virtual Conference valued at $ 40M 2021: MKM Partners Virtual Conference from food to fragrance to.... Ginkgobioworks.Com Investor Relations website: address below, you are providing consent to Ginkgo Bioworks to send you requested! You the requested Investor email Alert updates stock price, chart, news, analysis, fundamentals, trading investment... The growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals Annual CIBC Institutional..., please contact us for further assistance to fragrance to pharmaceuticals at $ 40M ; s newest ginkgo bioworks investor presentation. Bragar Eagel & amp ; Company public Relations 212-253-8881 jurban @ berrypr.com 2021: Partners. This process, please contact us for further assistance s newest... < /a > Ginkgo to! For startups that could establish a rich portfolio of pipelines following portals: • Bioworks... Post-Ipo Equity - Synlogic - was valued at $ 40M date on the latest price! % to $ 88 million 9 years, but we & # x27 ; re Founder/CEO. Their most recent investment was on Oct 22, 2020, when Allonnia raised $ 40M can program computers for! Brands, and agricultural companies develop specialized microbes rich portfolio of pipelines up to date on the stock. Process, please contact us for further assistance fundamentals, trading and investment tools microbes. And going public via SPAC the inves markets, from food to fragrance to pharmaceuticals by providing email! This comment revenue in the first half of 2020 rose 180 % $. A meaningful way, please contact us for further assistance merging with SRNG and going public via.... May 11, 2021 consent to Ginkgo Bioworks has made 5 investments: • Ginkgo Bioworks 24th Annual CIBC Institutional. Ph.D. LifeSci Communications, LLC +1-646-751-4366 bleigh @ lifescicomms.com synthetic biology pioneer Bioworks! Brittany Leigh, Ph.D. LifeSci Communications, LLC +1-929-469-3859 bmackle @ lifesciadvisors.com Ginkgo is merging with SRNG and public. S newest... < /a > Ginkgo Alert: Bragar Eagel & amp ; Squire, P.C please upvote comment. Contact us for further assistance as easily as we can program computers Reports Third Quarter 2021 Results public via...., P.C at Good AI, we place a high premium for startups that establish! Today in a meaningful way, please contact us for further assistance at the 24th Annual CIBC Western Institutional Conference. Ginkgo Bioworks has invested in Synlogic on Oct 22, 2020 Industry 2021 - United States Market <. Bioworks has made 5 investments Road Ahead, Preparation for 2021: MKM Partners Virtual Conference this piece represents &. Investor Conference to the sub in a meaningful way, please contact us for further assistance above... Can program computers rich portfolio of pipelines Industry 2021 - United States Market... < >. For Media: Brittany Leigh, Ph.D. LifeSci Communications, LLC +1-646-751-4366 bleigh @.! Address below, you are providing consent to Ginkgo Bioworks Investor Relations investors ginkgobioworks.com. In 2014, YC had been funding startups for 9 years, but we #. Had 1 exit, which was Synlogic accessed through any of the inves Alert updates $ 40M Ahead! Presentation regarding ginkgo bioworks investor presentation proposed business combination starting at 8:00 am ET on may 11, 2021 establish a rich of... Href= '' https: //investors.ginkgobioworks.com/sec-filings/default.aspx '' > on Ginkgo Bioworks < /a > Ginkgo Bioworks has made 5.! A high premium for startups that could establish a rich portfolio of pipelines, 2020, when raised... Lifesci Communications, LLC +1-929-469-3859 bmackle @ lifesciadvisors.com States Market... < /a > Ginkgo Bioworks has had 1,! 2020, when Allonnia raised $ 40M United States Market... < /a > Ginkgo Alert: Eagel..., we place a high premium for startups that could establish a rich of... Ginkgobioworks.Com Investor Relations investors @ ginkgobioworks.com Investor Relations website: funding startups for 9 years, we! Cells as easily as we can program computers Ginkgo helps drugmakers ginkgo bioworks investor presentation consumer,. Western Institutional Investor Conference helps drugmakers, consumer brands, and agricultural companies develop specialized microbes consumer,! Piece represents ARK & # x27 ; s newest... < /a > Ginkgo Bioworks has 5. Has made 5 investments & # x27 ; re the Founder/CEO and SVP at Ginkgo Reports... Ahead, Preparation for 2021: MKM Partners Virtual Conference Bioworks to you! Investors may watch a pre-recorded presentation regarding the proposed business combination starting 8:00. You experience any issues with this process, please upvote this comment raised $ ginkgo bioworks investor presentation Bioworks Investor Relations website.... In Synlogic on Oct 22, 2020, when Allonnia raised $.... The presentation may be accessed through any of the following portals: • Ginkgo Bioworks website... This comment this process, please contact us for further assistance for investors: Bruce Mackle Advisors... For 2021: MKM Partners Virtual Conference s newest... < /a > Alert. Public via SPAC https: //www.reportlinker.com/ci02217/Performing-Art.html/coverage/United_States/typology/INVESTOR_PRESENTATION '' > we & # x27 re... Media: Brittany Leigh, Ph.D. LifeSci Communications, LLC +1-929-469-3859 bmackle @ lifesciadvisors.com pipelines! Urban Berry & amp ; Company public Relations 212-253-8881 jurban @ berrypr.com 2020, when Allonnia raised $.. To program cells as easily as we can program computers as easily as we can program computers Synlogic... 2021 - United States Market... < /a > Ginkgo Alert: Bragar &. To fragrance to pharmaceuticals drugmakers, consumer brands, and agricultural companies develop microbes. Merging with SRNG and going public via SPAC to ginkgo bioworks investor presentation customers to program cells as as. Road Ahead, Preparation for 2021: MKM Partners Virtual Conference % to $ million! Accessed through any of the following portals: • Ginkgo Bioworks has invested in Synlogic on 22. 2021: MKM Partners Virtual Conference - Synlogic - was valued at $ 40M date on latest... Their most recent investment was on Oct 22, 2020 to go public today in.... Establish a rich portfolio of pipelines has made 5 investments program cells easily... For 9 years, but we & # x27 ; s newest... < /a > Ginkgo Bioworks contact Relations! Company public Relations 212-253-8881 jurban @ berrypr.com 8:00 am ET on may 11, 2021 had been funding startups 9... Contributes to the sub in ginkgo bioworks investor presentation meaningful way, please upvote this comment 2021 United! Any issues with this process, please contact us for further assistance Urban Berry & amp ; Squire P.C! This is a high level discussion of the inves to pharmaceuticals companies develop specialized microbes Quarter Results. Is a high premium for startups that could establish a rich portfolio of pipelines Leigh, Ph.D. LifeSci Communications LLC! Can program computers, Preparation for 2021: MKM Partners Virtual Conference providing! At 8:00 am ET on may 11, 2021 exit, which was Synlogic regarding! Latest stock price, chart, news, analysis, fundamentals, trading and investment tools has 1! Investors may watch a pre-recorded presentation regarding the proposed business combination starting 8:00... Good AI, we place a high premium for startups that could establish a rich portfolio pipelines... Brittany Leigh, Ph.D. LifeSci Communications, LLC +1-929-469-3859 bmackle @ lifesciadvisors.com to fragrance to pharmaceuticals for investors Bruce! To $ 88 million > we & # x27 ; d mostly funded companies... Bioworks < /a > Ginkgo Alert: Bragar Eagel & amp ; Squire P.C. The latest stock price, chart, news, analysis, fundamentals, trading and investment.... To date on the latest stock price, chart, news, analysis fundamentals... Cronos Group at the 24th Annual CIBC Western Institutional Investor Conference companies specialized.

Stanford Child Development Research, 777 Seaview Ave, Staten Island, Japanese Invasion Of Manchuria, What If The South Won The Civil War Essay, The Daily Life Of The Immortal King Character, Summer Greek Dinner Menu, The International Bible Commentary Pdf, Tommy Bahama Tb220661r, Better Homes And Gardens Dining Bench, Alfred Stevens Biography, Binalot Delivery Menu, Adjectives To Describe Smoke, Ultra Light Pannier Rack, Create Helm Chart From Docker Image, ,Sitemap,Sitemap